Icariin attenuates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome through SIRT3-mediated TFAM deacetylation
Min Sun, Hui Huang, Chao Wei, Yuan Xing, Bing Wu · 2026
Read Icariin attenuates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome through SIRT3-mediated TFAM deacetylation by Min Sun, Hui Huang, Chao Wei, Yuan Xing, Bing Wu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13261754.txt.
Description
Min Sun and colleagues tested in 2026 whether icariin, a compound from the herb Epimedium, protects the diabetic heart by quieting an inflammatory alarm. In diabetic cardiomyopathy the heart thickens, scars, and weakens, and the NLRP3 inflammasome helps drive that course. Their experiments used diabetic mice and rat heart cells bathed in high sugar.
Treated mice showed less heart thickening and scarring, with better pumping function. The compound lowered mitochondrial reactive oxygen, stray mitochondrial DNA in the cell fluid, inflammasome firing, and a fiery form of cell death. Inside cells, it raised the activity of SIRT3, an enzyme that strips chemical tags from a mitochondrial gene-reading factor. Blocking that enzyme chain removed much of the benefit, tying the protection to the pathway. The authors propose icariin as a candidate for diabetic heart care.
Catalog record
| CREATOR | Min Sun, Hui Huang, Chao Wei, Yuan Xing, Bing Wu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |